Position in JNJ
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$742,608
-$21,267 QoQ
Shares Held
2,924
-6.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#3,295
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VALLEY WEALTH MANAGERS, INC. holds $73,144,237 across 11 Drug Manufacturers - General names. JNJ ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
70,456 | $25,513,525 | |
| 2 | PFE |
Pfizer Inc
|
1,014,187 | $24,421,622 | |
| 3 | ABBV |
AbbVie Inc.
|
27,537 | $6,929,410 | |
| 4 | MRK |
Merck & Co., Inc.
|
50,079 | $6,435,151 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
37,151 | $4,693,657 | |
| 6 | LLY |
ELI LILLY & Co
|
3,395 | $4,072,065 | |
| 7 | JNJ |
Johnson & Johnson
This page
|
2,924 | $742,608 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,000 | $115,240 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $742,608 | 2,924 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $763,875 | 3,125 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $5,569,851 | 26,914 | Shares | Defined | 2026-02-04 | |
| 2025-09-30 | $5,067,528 | 27,330 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $4,001,285 | 26,195 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $4,175,850 | 25,180 | Shares | Defined | 2025-05-07 | |
| 2024-12-31 | $3,423,154 | 23,670 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $3,712,308 | 22,907 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $3,359,633 | 22,986 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $3,746,096 | 23,681 | Shares | Defined | 2024-05-03 | |
| 2023-12-31 | $18,700,805 | 119,311 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $18,244,710 | 117,141 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $19,905,766 | 120,262 | Shares | Defined | 2023-07-28 | |
| 2023-03-31 | $19,022,375 | 122,725 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $21,470,393 | 121,542 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $20,325,251 | 124,420 | Shares | Defined | 2022-11-09 | |
| 2022-03-31 | $22,967,058 | 129,589 | Shares | Other | 2022-05-02 | |
| 2021-12-31 | $21,604,430 | 126,290 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $20,306,041 | 125,734 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $20,754,933 | 125,986 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $20,223,267 | 123,050 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $19,156,922 | 121,724 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $17,959,691 | 120,632 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $16,764,501 | 119,210 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $15,762,480 | 120,205 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||